Literature DB >> 33313053

Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HS.

Angelo Ruggiero1, Gabriella Fabbrocini1, Matteo Megna1, Giuseppe Monfrecola1, Claudio Marasca1.   

Abstract

INTRODUCTION: Hidradenitis suppurativa (HS) is an inflammatory skin disease, which usually occurs after puberty. Even if the pathogenesis of HS is still unproven, numerous studies hypothesized that the disease is triggered by genetic and environmental factors, with hormones playing a central role. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is a congenital malformation in which a failure of Müllerian duct development results in absent uterus and fallopian tubes and malformations of the vagina. CASE
PRESENTATION: A 38-year-old Caucasian female referred at our outpatient clinic affected by HS. Before the appearance of HS manifestations, the patient referred to a gynecologist due to difficulties in getting pregnant. The sonographic findings were consistent with MRKH syndrome. An ovarian stimulation for in vitro fertilization was started. However, after 3 months the patient showed the first HS onset. After the hormonal treatment ended, a combined treatment with rifampicin and clindamycin was started, showing a great clinical improvement at week 10. DISCUSSION/
CONCLUSION: HS usually appears after puberty, exhibits premenstrual flare, improves in pregnancy, and worsens postpartum, which indicates a role of hormones and particularly of androgens in its pathophysiology. Contrasting data are reported in the literature. Our case wants to strengthen the idea that hormones could play an important role, probably with other endogenous or exogenous factors. Multidisciplinary investigations will clarify which part is played by each factor in the pathogenesis of HS.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Hidradenitis suppurativa; Hormones; Mayer-Rokitansky-Küster-Hauser syndrome

Year:  2020        PMID: 33313053      PMCID: PMC7706494          DOI: 10.1159/000508669

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  20 in total

1.  Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance.

Authors:  C Marasca; A Masarà; M C Annunziata; V Bettoli; M A Luciano; G Fabbrocini
Journal:  Br J Dermatol       Date:  2019-01-01       Impact factor: 9.302

2.  Hyperandrogenemia and ovarian reserve in patients with Mayer-Rokitansky-Küster-Hauser syndrome type 1 and 2: potential influences on ovarian stimulation.

Authors:  Melanie Henes; Ludmila Jurow; Andreas Peter; Birgitt Schoenfisch; Florin Andrei Taran; Markus Huebner; Harald Seeger; Sara Yvonne Brucker; Kristin Katharina Rall
Journal:  Arch Gynecol Obstet       Date:  2017-11-24       Impact factor: 2.344

3.  Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data.

Authors:  Georgios Nikolakis; Athanassios Kyrgidis; Christos C Zouboulis
Journal:  Am J Clin Dermatol       Date:  2019-08       Impact factor: 7.403

Review 4.  Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.

Authors:  Dunja Ana Vekic; John Frew; Geoffrey David Cains
Journal:  Australas J Dermatol       Date:  2018-01-21       Impact factor: 2.875

Review 5.  The Role of Androgens and Estrogens in Hidradenitis Suppurativa - A Systematic Review.

Authors:  Peter Theut Riis; Hans Christian Ring; Lotte Themstrup; Gregor Borut Jemec
Journal:  Acta Dermatovenerol Croat       Date:  2016-12       Impact factor: 1.256

Review 6.  What is hidradenitis suppurativa?

Authors:  Erika Yue Lee; Raed Alhusayen; Perla Lansang; Neil Shear; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

7.  Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa.

Authors:  J H Barth; T Kealey
Journal:  Br J Dermatol       Date:  1991-10       Impact factor: 9.302

8.  What causes hidradenitis suppurativa?

Authors:  H Kurzen; I Kurokawa; G B E Jemec; L Emtestam; K Sellheyer; E J Giamarellos-Bourboulis; I Nagy; F G Bechara; K Sartorius; J Lapins; D Krahl; P Altmeyer; J Revuz; C C Zouboulis
Journal:  Exp Dermatol       Date:  2008-05       Impact factor: 3.960

Review 9.  Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?

Authors:  Ioannis Karagiannidis; Georgios Nikolakis; Robert Sabat; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

10.  Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy.

Authors:  John N Kraft; Gordon E Searles
Journal:  J Cutan Med Surg       Date:  2007 Jul-Aug       Impact factor: 2.092

View more
  1 in total

Review 1.  Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review.

Authors:  Angelo Ruggiero; Fabrizio Martora; Vincenzo Picone; Laura Marano; Gabriella Fabbrocini; Claudio Marasca
Journal:  Biomedicines       Date:  2022-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.